Extralabel Use of Anesthetic and Analgesic Compounds in Cattle

Veterinary Clinics of North America - Food Animal Practice

Volumn 29, Issue 1, 2013, Pages 29-45

  Smith, Geof ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Analgesia; Anesthesia; Pain management; Pharmacology; Residues; Withdrawal

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; DRUG RESIDUE;

ANALGESIA; ANESTHESIA; ANIMAL; ANIMAL DISEASE; CATTLE; CATTLE DISEASE; CHEMISTRY; MEAT; METHODOLOGY; MILK; OFF LABEL DRUG USE; PAIN; REVIEW;

ANALGESIA; ANALGESICS; ANESTHESIA; ANESTHETICS; ANIMALS; CATTLE; CATTLE DISEASES; DRUG RESIDUES; MEAT; MILK; OFF-LABEL USE; PAIN;

EID: 84874240486     PISSN: 07490720     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvfa.2012.11.003     Document Type: Review

References (62)

1. Craigmill A.L., Rangel-Lugo M., Damian P., et al. Extralabel use of tranquilizers and general anesthetics. J Am Vet Med Assoc 1997, 211:302-304.
2. Smith G.W., Davis J.L., Tell L.A., et al. Extralabel use of nonsteroidal anti-inflammatory drugs in cattle. J Am Vet Med Assoc 2008, 232:697-701.
3. Gingerich D.A., Baggot J.D., Yeary R.A. Pharmacokinetics and dosage of aspirin in cattle. J Am Vet Med Assoc 1975, 167:945-948.
4. Coetzee J.F., Gehring R., Bettenhausen A.C., et al. Attenuation of acute plasma cortisol response in calves following intravenous sodium salicylate administration prior to castration. J Vet Pharmacol Ther 2007, 30:305-313.
5. Baldridge S.L., Coetzee J.F., Dritz S.S., et al. Pharmacokinetics and physiologic effects of intramuscularly administered xylazine hydrochloride-ketamine hydrochloride-butorphanol tartrate alone or in combination with orally administered sodium salicylate on biomarkers of pain in Holstein calves following castration and dehorning. Am J Vet Res 2011, 72:1305-1317.
6. Kotschwar J.L., Coetzee J.F., Anderson D.E., et al. Analgesic efficacy of sodium salicylate in an amphotericin B-induced bovine synovitis-arthritis model. J Dairy Sci 2009, 92:3731-3743.
7. Court M.H., Dodman N.H., Levine H.D., et al. Pharmacokinetics and milk residues of butorphanol in dairy cows after single intravenous administration. J Vet Pharmacol Ther 1992, 15:28-35.
8. Lohuis J.A., van Werven T., Brand A., et al. Pharmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin-induced mastitis. J Vet Pharmacol Ther 1991, 14:219-229.
9. Ludwig B., Jordan J.C., Rehm W.F., et al. Carprofen in veterinary medicine 1. Plasma disposition, milk excretion and tolerance in milk-producing cows. Schweiz Arch Tierheilkd 1989, 131:99-106.
10. European Agency for the Evaluation of Medicinal Products-Committee for Veterinary Medicinal Products: Carprofen. Available at: Accessed August 1, 2012. http://www.emea.europa.eu/pdfs/vet/mrls/091404en.pdf.
11. Lin H.C., Riddell M. Preliminary study of the effects of xylazine or detomidine with or without butorphanol for standing sedation in dairy cattle. Vet Ther 2003, 4:285-291.
12. Prado M.E., Streeter R.N., Mandsager R.E., et al. Pharmacologic effects of epidural versus intramuscular administration of detomidine in cattle. Am J Vet Res 1999, 60:1242-1247.
13. Salonen J.S., Vähä-Vahe T., Vainio O., et al. Single-dose pharmacokinetics of detomidine in the horse and cow. J Vet Pharmacol Ther 1989, 12:65-72.
14. United States Department of Agriculture-Food Safety Inspection Service. Red book. 2005-2010. Available at: Accessed August 1, 2012. http://www.fsis.usda.gov/Science/2005_Red_Book/index.asp.
15. Anderson K.L., Neff-Davis C.A., Davis L.E., et al. Pharmacokinetics of flunixin meglumine in lactating cattle after single and multiple intramuscular and intravenous administrations. Am J Vet Res 1990, 51:1464-1467.
16. Odensvik K., Johansson I.M. High-performance liquid chromatography method for determination of flunixin meglumine in bovine plasma and pharmacokinetics after single and repeated doses of the drug. Am J Vet Res 1995, 56:489-495.
17. Kissell L.W., Smith G.W., Leavens T.L., et al. Plasma pharmacokinetics and milk residues of flunixin and 5-hydroxy flunixin following different routes of administration in dairy cattle. J Dairy Sci 2012, 95:7151-7157.
18. Lichtenwalner D.M., Cameron B.D., Young C. The metabolism and pharmacokinetics of flunixin meglumine in cows and steers. Proceedings of the 14th World Congress on Diseases of Cattle 1986, 1179-1183. Irish Cattle Veterinary Association, Dublin (Ireland). P.J. Hartigan, M.L. Monaghan (Eds.).
19. Clement R.P., Simmons R.D., Christopher R.J., et al. Design and conduct of studies to meet residue chemistry requirements; residue depletion and metabolism of flunixin meglumine in cattle. Xenobiotics and food-producing animals 1992, 37-48. Oxford University Press, New York. D.H. Hutson, D.R. Hawkins, G.D. Paulson (Eds.).
20. Odensvik K. Pharmacokinetics of flunixin meglumine and its effect on prostaglandin F2 alpha metabolite concentrations after oral and intravenous administration in heifers. J Vet Pharmacol Ther 1995, 18:254-259.
21. 14C-flunixin meglumine. J Agric Food Chem 2002, 50:7308-7313.
22. Hurley R.W., Chatterjea D., Rose Feng M., et al. Gabapentin and pregabalin can interact synergistically with naproxen to produce antiphyeralgesia. Anesthesiology 2002, 97:1263-1273.
23. Coetzee J.F., Mosher R.A., Kohake L.E., et al. Pharmacokinetics of oral gabapentin alone or co-administered with meloxicam in ruminant beef calves. Vet J 2011, 190:98-102.
24. Malreddy PR, Coetzee JF, KuKanich B, et al. Pharmacokinetics and milk secretion of gabapentin and meloxicam co-administered orally with Holstein-Friesian cows. J Vet Pharmacol Ther, in press.
25. Waterman A.E. The pharmacokinetics of ketamine administered intravenously in calves and the modifying effect of premedication with xylazine hydrochloride. J Vet Pharmacol Ther 1984, 7:125-130.
26. Gehring R., Coetzee J.F., Tarus-Sang J., et al. Pharmacokinetics of ketamine and its major metabolite norketamine administered at a sub-anesthetic dose together with xylazine to calves prior to castration. J Vet Pharmacol Ther 2008, 32:124-128.
27. Sellers G., Lin H.C., Riddell M.G., et al. Pharmacokinetics of ketamine in plasma and milk of mature Holstein cows. J Vet Pharmacol Ther 2010, 33:480-484.
28. DeGraves F.J., Riddell M.G., Schumacher J. Ketoprofen concentrations in plasma and milk after intravenous administration in dairy cattle. Am J Vet Res 1996, 57:1031-1033.
29. European Agency for the Evaluation of Medicinal Products-Committee for Veterinary Medicinal Products. Ketoprofen. Available at: Accessed August 1, 2012. http://www.emea.europa.eu/pdfs/vet/mrls/002095en.pdf.
30. Pyörälä S., Laurila T., Lehtonen S., et al. Local tissue damage in cows after intramuscular administration of preparations containing phenylbutazone, flunixin meglumine, ketoprofen and metamizole. Acta Vet Scand 1999, 40:145-150.
31. Cox S., Wilson J., Doherty T. Pharmacokinetics of lidocaine after intravenous administration to cows. J Vet Pharmacol Ther 2011, 35:305-308.
32. Sellers G., Lin H.C., Riddell M.G., et al. Pharmacokinetics of lidocaine in serum and milk of mature Holstein cows. J Vet Pharmacol Ther 2009, 32:446-450.
33. Bednarek D., Zdzisinska B., Kondracki M., et al. A comparative study of the effects of meloxicam and flunixin meglumine (NSAIDs) as adjunctive therapy on interferon and tumor necrosis factor production in calves suffering from enzootic bronchopneumonia. Pol J Vet Sci 2003, 6:109-115.
34. Friton G.M., Cajal C., Ramirez Romero R., et al. Clinical efficacy of meloxicam (Metacam) and flunixin meglumine (Finadyne) as adjuncts to antibacterial treatment of respiratory disease in fattening cattle. Berl Munch Tierarztl Wochenschr 2004, 117:304-309.
35. Coetzee J.F., Edwards L.N., Mosher R.A., et al. Effect of oral meloxicam on health and performance of beef steers relative to bulls castrated on arrival at the feedlot. J Anim Sci 2012, 90:1026-1039.
36. Theurer M.E., White B.J., Coetzee J.F., et al. Assessment of behavioral changes associated with oral meloxicam administration at time of dehorning in calves using a remote triangulation device and accelerometers. BMC Vet Res 2012, 8:48.
37. Heinrich A., Duffield T.F., Lissemore K.D., et al. The effect of meloxicam on behavior and pain sensitivity to dairy calves following cautery dehorning with a local anesthetic. J Dairy Sci 2010, 93:2450-2457.
38. Todd C.G., Millman S.T., McKnight D.R., et al. Nonsteroidal anti-inflammatory drug therapy for neonatal calf diarrhea complex: effects on calf performance. J Anim Sci 2010, 88:2019-2028.
39. Coetzee J.F., KuKanich B., Mosher R., et al. Pharmacokinetics of intravenous and oral meloxicam in ruminant calves. Vet Ther 2009, 10:E1-E8.
40. Mosher R.A., Coetzee J.F., Cull C.A., et al. Pharmacokinetics of oral meloxicam in ruminant and preruminant calves. J Vet Pharmacol Ther 2011, 35:373-381.
41. Riviere J.E., Sundlof S.F. Chemical residues in tissues of food animals. Veterinary pharmacology and therapeutics 2009, 1453-1462. Wiley-Blackwell, Ames (IA). 9th edition. J.E. Riviere, M.G. Papich (Eds.).
42. Martin K., Andersson L., Stridsberg M., et al. Plasma concentration, mammary excretion and side effects of phenylbutazone after repeated oral administration in healthy cows. J Vet Pharmacol Ther 1984, 7:131-138.
43. Davis J.L., Smith G.W., Baynes R.E., et al. Update on drugs prohibited from extralabel use in food animals. J Am Vet Med Assoc 2009, 235:528-534.
44. Lees P., Ayliffe T., Maitho T.E., et al. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration. Res Vet Sci 1988, 44:57-67.
45. Arafat A.K., Lees P. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves. J Vet Pharmacol Ther 2002, 25:299-309.
46. de Veau I.F., Pedersoli W., Cullison R., et al. Pharmacokinetics of phenylbutazone in beef steers. J Vet Pharmacol Ther 2002, 25:195-200.
47. de Veau E.J., Pedersoli W., Cullison R., et al. Pharmacokinetics of phenylbutazone in plasma and milk of lactating dairy cows. J Vet Pharmacol Ther 1998, 21:437-443.
48. Semrad S.D., McClure J.T., Sams R.A., et al. Pharmacokinetics and effects of repeated administration of phenylbutazone in neonatal calves. Am J Vet Res 1993, 54:1906-1912.
49. Volner Z., Nouws J.F., Kozjek F., et al. Age-dependent pharmacokinetics of phenylbutazone in calves. Vet Q 1990, 12:98-102.
50. Williams R.J., Boudinot F.D., Smith J.A., et al. Pharmacokinetics of phenylbutazone in mature Holstein bulls: steady-state kinetics after multiple oral dosing. Am J Vet Res 1990, 51:371-375.
51. Williams R.J., Smith J.A., Boudinot F.D., et al. Pharmacokinetics of phenylbutazone given intravenously or orally in mature Holstein bulls. Am J Vet Res 1990, 51:367-370.
52. Toutain P.L., Alvinerie M., Ruckebusch Y. Pharmacokinetics and residue levels of phenylbutazone in the cow. Ann Rech Vet 1980, 11:391-397.
53. Ferre P.J., Laroute V., Braun J.P., et al. Simultaneous and minimally invasive assessment of muscle tolerance and bioavailability of different volumes of an intramuscular formulation in the same animals. J Anim Sci 2006, 84:1295-1301.
54. Chamberlain P.L., Fowler B.A., Sexton M.J., et al. Preliminary studies of offspring exposure to phenylbutazone and ivermectin during the perinatal period in a Holstein cow-calf model. Toxicol Appl Pharmacol 2003, 187:198-208.
55. Cagnardi P., Zonca A., Gallo M., et al. Pharmacokinetics of propofol in calves undergoing abdominal surgery. Vet Res Commun 2009, 33(Suppl 1):S177-S179.
56. Delehant T.M., Denhart J.W., Lloyd W.E., et al. Pharmacokinetics of xylazine, 2,6-dimethylaniline, and tolazoline in tissues from yearling cattle and milk from mature dairy cows after sedation with xylazine hydrochloride and reversal with tolazoline hydrochloride. Vet Ther 2003, 4:128-134.
57. Haskell S.R., Gehring R., Payne M.A., et al. Update on FARAD food animal drug withholding recommendations. J Am Vet Med Assoc 2003, 223:1277-1278.
58. Landoni M.R., Cunningham F.M., Lees P. Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. Res Vet Sci 1996, 61:26-32.
59. Sidhu P.K., Landoni M.F., Lees P. Influence of marbofloxacin on the pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. J Vet Pharmacol Ther 2005, 28:109-119.
60. European Agency for the Evaluation of Medicinal Products-Committee for Veterinary Medicinal Products: Tolfenamic acid. Available at: Accessed August 1, 2012. http://www.emea.europa.eu/pdfs/vet/mrls/018397en.pdf.
61. Garcia-Villar R., Toutain P., Alvinerie M., et al. The pharmacokinetics of xylazine hydrochloride: an interspecific study. J Vet Pharmacol Ther 1981, 4:87-92.
62. Jernigan A.D., Wilson R.C., Booth N.H., et al. Comparative pharmacokinetics of yohimbine in steers, horses and dogs. Can J Vet Res 1988, 52:172-176.